SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Genlink Pharma Solutions informs about financial results

16 Nov 2019 Evaluate

Genlink Pharma Solutions has informed about submission of financial results along with limited review report for the half year ended 30th September, 2019 and certificate by debenture trustee pursuant to regulation 52 of SEBI (LODR), 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
PropShare Celestia 1014000.00
ICICINXT50 76.60
Citius Transnet Inve 105.90
EMAMILTD7 423.00
Bagmane Prime Office 102.38
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: